Transformation of pharmaceutical care during the matrial state in Ukraine: doctors' perception of interprofessional communication.

Abstract

Objective: Aim: To investigate the perception of general practitioners of family medicine of the implementation of Good Pharmacy Practice (GPP) standards by pharmacists to determine approaches to interprofessional communication and further integration of pharmacists into primary health care.

Patients and methods: Materials and Methods: The study was conducted at the Department of Cardiology of the Shupyk National Healthcare University of Ukraine from March to December 2024 by means of an anonymous online survey using Google Forms. The methods of analysis, deduction, induction, comparison, systematization, generalization, forecasting, statistics and bibliography were used.

Results: Results: The functions of pharmacists in integrated care teams were determined: monitoring and compatibility of medicines, monitoring the effectiveness of pharmacotherapy, dispensing prescription medicines "only on prescription" (72.5% [CI 95% 72.5 ± 0.02, p<0.0001]); joint training in the process of continuous professional development (4.8% [CI 95% 4.8 ± 0.01, p<0.0001]). It was found that the level of clinical competencies of pharmacists (65.3% [CI 95% 65.3 ± 0.03, p<0.0001]) and safe use of medicines (60.7% [CI 95% 60.7, ± 0.03, p<0.0001]) is mediocre.

Conclusion: Conclusions: The high interest of doctors of therapeutic specialties in interprofessional communication with pharmacists as part of integrated care teams was determined (72.5% [CI 95% 72.5 ± 0.02, p<0.0001]). The need for additional training of pharmacists in the process of continuous professional development for work as part of integrated care teams in order to obtain and deepen clinical competencies was substantiated. We see the development of clinical recommendations for community pharmacists in accordance with the ESC/AHA recommendations and taking into account the compatibility of medicines when providing pharmaceutical care to patients with ischemic heart disease with comorbid conditions as a prospect for further research.